Haloperidol - Therapeutic use
Research News and Information

Sunday, November 22, 2009

Combination of electroconvulsive therapy with skin graft surgery for a schizophrenic patient with burns.

30 Aug 2009 We report on the use of electroconvulsive therapy (ECT) on a patient with schizophrenia immediately after skin graft surgery for extensive burns. The patient was 22 years old and had been burned in more than 33% of his body because of a suicide ... Read more...

Efficacy and tolerability of switching to ziprasidone from olanzapine, risperidone or haloperidol: an international, multicenter study.

30 Aug 2009 To compare the effectiveness of a switch from haloperidol (N=99), olanzapine (N=82), or risperidone (N=104) to 12 weeks of treatment with 80-160 mg/day ziprasidone in patients with stable schizophrenia or schizoaffective disorder. Stable outpatients ... Read more...

Chorea associated with gabapentin use in an elderly man.

30 Jul 2009 BACKGROUND: Chorea is a hyperkinetic movement disorder characterized by irregular, flowing, nonstereotyped, random, involuntary movements. Huntington disease (HD) and drug-induced chorea account for >50% of adult-onset cases. Chorea associated with ... Read more...

Latest indexed articles for 'Haloperidol - Therapeutic use'

These are the very latest articles for this heading:

• Combination of electroconvulsive therapy with skin graft surgery for a schizophrenic patient with burns. 30 Aug 2009
• Fatal pulmonary embolism following antipsychotic treatment and physical restraint. 30 Aug 2009
• Efficacy and tolerability of switching to ziprasidone from olanzapine, risperidone or haloperidol: an international, multicenter study. 30 Aug 2009
• Chorea associated with gabapentin use in an elderly man. 30 Jul 2009
• Nausea and vomiting after office-based anesthesia. 30 Jul 2009
• Relationships among neurocognition, symptoms and functioning in patients with schizophrenia: a path-analytic approach for associations at baseline and following 24 weeks of antipsychotic drug therapy. 12 Jul 2009
• Haloperidol plus promethazine for psychosis-induced aggression. 6 Jul 2009
• [Efficacy of clonidine transdermal patch for treatment of Tourette's syndrome in children] 29 Jun 2009
• Targeting pain-depressed behaviors in preclinical assays of pain and analgesia: drug effects on acetic acid-depressed locomotor activity in ICR mice. 22 Jun 2009
• Tackling agitated delirium--the tip of the iceberg. 16 Jun 2009
• The efficacies of clozapine and haloperidol in refractory schizophrenia are related to DTNBP1 variation. 30 May 2009
• Differential expression of metabotropic glutamate receptors 2 and 3 in schizophrenia: a mechanism for antipsychotic drug action? 30 May 2009
• Targeting cognition in schizophrenia research: from etiology to treatment. 30 May 2009
• Dopamine D2/3 receptor binding potential and occupancy in midbrain and temporal cortex by haloperidol, olanzapine and clozapine. 20 May 2009
• The treatment of challenging behaviour in intellectual disabilities: cost-effectiveness analysis. 19 May 2009
• Dexmedetomidine vs. haloperidol in delirious, agitated, intubated patients: a randomised open-label trial. 17 May 2009
• Rationale and design of an independent randomised controlled trial evaluating the effectiveness of aripiprazole or haloperidol in combination with clozapine for treatment-resistant schizophrenia. 13 May 2009
• Neurocognitive effectiveness of haloperidol, risperidone, and olanzapine in first-episode psychosis: a randomized, controlled 1-year follow-up comparison. 29 Apr 2009
• Reduced neuronal expression of insulin-degrading enzyme in the dorsolateral prefrontal cortex of patients with haloperidol-treated, chronic schizophrenia. 21 Apr 2009
• Haloperidol for the treatment of nausea and vomiting in palliative care patients. 13 Apr 2009

See a longer list of these articles.

Technical information about 'Haloperidol'

Definition: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in MENTAL RETARDATION and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)

Chemical name: 1-Butanone, 4-(4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl)-1-(4-fluorophenyl)-

Registry Number: 52-86-8

Descriptor UI: D006220

Alternative terms: Haloperidol; Haldol;

Allowable Qualifiers: administration & dosage; adverse effects; analogs & derivatives; analysis; antagonists & inhibitors; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;

Pharmacological Action: Antiemetics; Antipsychotic Agents; Dopamine Antagonists; Anti-Dyskinesia Agents;

Tree Number: D02.522.352.506;